首页> 外文期刊>The Tohoku Journal of Experimental Medicine >Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study.
【24h】

Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study.

机译:2型糖尿病患者的亚临床甲状腺功能减退症与增生性糖尿病视网膜病变之间的关联:病例对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Subclinical hypothyroidism (SCH) is defined as an asymptomatic state characterized by normal serum levels of free thyroxine and elevated serum concentrations of thyrotropin (> 4.0 microU/ml). The association between SCH and type 2 diabetes has been well established. Proliferative diabetic retinopathy (PDR) that is characterized by neovascularization is a leading cause of visual loss in adults worldwide. However, whether SCH is related to PDR has not been studied. This study thus aimed to evaluate the relationship between SCH and PDR in type 2 diabetes. A total of 371 type 2 diabetic subjects were enrolled: 187 subjects with PDR and 184 subjects without diabetic retinopathy (with HbA1c above 6.5% and at least 10 years of diabetes duration). Subjects with PDR had higher blood pressure, higher serum levels of total cholesterol, low-density lipoprotein cholesterol and thyrotropin, and higher urinary albumin excretion rate. Of the 371 diabetics, 83 subjects (22.4%) were diagnosed as SCH (male 12.1% and female 29.9%). The prevalence of SCH in the PDR group (51/187, 27.3%) was higher than that in the subjects without diabetic retinopathy (32/184, 17.4%). Logistic regression analysis showed that after adjusting for compounding variables, SCH was independently related with PDR (p = 0.032, adjusted OR = 2.485). These results indicate that type 2 diabetic patients with PDR are at an increased risk of SCH. A routine screening for thyroid function may thus be considered advisable in PDR subjects. This may be helpful in investigating new strategies preventing or treating PDR in clinical practice.
机译:亚临床甲状腺功能减退症(SCH)定义为无症状状态,其特征在于正常血清中的游离甲状腺素水平和升高的促甲状腺激素血清浓度(> 4.0 microU / ml)。 SCH与2型糖尿病之间的关联已得到很好的确立。以新血管形成为特征的增生性糖尿病视网膜病变(PDR)是全世界成人视力丧失的主要原因。但是,尚未研究SCH是否与PDR有关。因此,本研究旨在评估2型糖尿病中SCH与PDR之间的关系。总共招募了371位2型糖尿病患者:187位PDR患者和184位无糖尿病视网膜病变(HbA1c高于6.5%,且糖尿病持续时间至少10年)的患者。患有PDR的受试者的血压更高,血清总胆固醇水平更高,低密度脂蛋白胆固醇和促甲状腺激素水平更高,尿白蛋白排泄率更高。在371位糖尿病患者中,有83位受试者(22.4%)被诊断为SCH(男性12.1%,女性29.9%)。 PDR组的SCH患病率(51/187,27.3%)高于无糖尿病性视网膜病变的受试者(32/184,17.4%)。 Logistic回归分析表明,在调整了复合变量之后,SCH与PDR独立相关(p = 0.032,调整后的OR = 2.485)。这些结果表明2型糖尿病PDR患者的SCH风险增加。因此,在PDR受试者中,常规筛查甲状腺功能可能被认为是明智的。这可能有助于研究在临床实践中预防或治疗PDR的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号